GlassScriptPhysician profile
Melissa C Giese
NPI 1437498664
$2,044.39
in general payments reported to CMS, 2019-2025
27 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $555 · 2023: $830 · 2024: $242 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.03 |
| Education | $135.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $268.33 | 2022-2023 | |
| Astellas Pharma US INC | $245.29 | 2021-2023 | Myrbetriq |
| Janssen Biotech, INC. | $187.25 | 2021-2024 | Erleada |
| Progenics Pharmaceuticals, INC. | $136.66 | 2023-2024 | Pylarify |
| Sumitomo Pharma America, INC. | $135.75 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $126.70 | 2022-2023 | Xiaflex |
| Valencia Technologies Corporation | $89.58 | 2025 | Ecoin Device Kit |
| Bayer Healthcare Pharmaceuticals INC. | $88.91 | 2022-2023 | |
| Urovant Sciences INC | $85.99 | 2021-2022 | |
| Myovant Sciences INC. | $81.98 | 2022 | |
| Blue Earth Diagnostics | $73.02 | 2023-2024 | |
| Teleflex LLC | $66.34 | 2023 | Urolift |
| Abbvie INC. | $66.07 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $52.87 | 2022 | |
| Tolmar, INC. | $52.49 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.28 | 2022-2023 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Medtronic, INC. | $31.74 | 2022 | |
| Dendreon Pharmaceuticals LLC | $28.16 | 2023 | Provenge |
| Accord Healthcare, INC. | $24.07 | 2023 | |
| Palette Life Sciences, INC. | $23.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.71 | 2025 | |
| Olympus America INC. | $20.40 | 2023 | Itind System |
| Bioprotect Medical, INC. | $18.67 | 2025 | Bioprotect Balloon Implant System |
| Ethicon US, LLC | $16.24 | 2023 | Stratafix |
| Acerus Pharmaceuticals Corporation | $15.78 | 2022 | |
| Hollister Incorporated | $14.08 | 2023 | Vapro, Infyna Chic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Giese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.